Here, we tested this idea and report that survival of at least some CRC cell lines does not require any TCF/LEF expression, and that several randomly chosen CRC cell lines even tolerate inactivation of β-CATENIN. The gene discussed is HNF4A; the disease is colorectal carcinoma.